Kyntra Bio targets FG-3246 median rPFS of 10 months or greater as it plans roxadustat Phase III start in Q4 2026 — See source for full details.
$KYNB
Price history, market instrument context, member research, and related headlines in one place.
KYNB key statistics
NasdaqGSUSD
52-week range
$5.340%$11.65
Latest session $5.34–$5.73Kyntra Bio, Inc. (KYNB) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $5.36, down $0.21 (3.68%) from the previous close of $5.57. It has traded between $5.34 and $5.73 in the latest session. Over the past year it has ranged from $5.34 to $11.65, leaving it trading near the bottom of its 52-week range. Reported volume for the session was 31.6K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Loading $KYNB research…